Feb 19,2021

MyWay Digital Health Win Courier Business Award

MyWay win the ‘Enterprise in Education’ award 28.10.17 at the annual Courier Business Awards. This award is open to all spin-out companies formed out of research or ideas generated from within the education sector and also to spin-in companies who use the services of an education institution to turn a concept into a commercial reality and develop an existing business.

View Analyst & Ambassador Comments
Go to original news
Oct 02,2017

Insulet Corporation to Announce Third Quarter 2017 Financial Results on November 2, 2017

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the third quarter of 2017 on November 2, 2017 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Oct 03,2017

DarioHealth Launches into the German Diabetes Market

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it expands its global reach with a successful launch into the German market, making its smart diabetes platform available for the first time in the EU's largest market, both by population and GDP.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Oct 06,2017

Insulet Offers Welcome Program for Animas® Users to Try Omnipod® Insulin Management System at Zero Cost

Insulet Corporation's (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), is offering the Omnipod® Welcome Program for existing Animas® insulin pump users as part of the Company's commitment to the diabetes community. This program provides users with a no cost trial of the Omnipod System.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Oct 07,2017

App way to manage gestational diabetes

Doctors at the National University Hospital (NUH) hope that a mobile app, which can track a patient's weight and blood glucose levels, can help pregnant women with gestational diabetes. NUH is now conducting clinical trials with Jana Care. The trial was started last month and has involved 20 women with gestational diabetes. The goal is to recruit 340 in the next 10 months. Half the participants will use the app as well as a special weighing scale, and the rest will be in a control group.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 08,2017

Global Reinsurance Leader Swiss Re Engages With Wellthy Therapeutics for its 2017 InsurTech Accelerator

Wellthy Therapeutics, a Digital Therapeutics company based out of Mumbai, is one of the five companies selected, and the only Healthcare company to enrol into Swiss Re InsurTech Accelerator programme this year. Wellthy's artificial intelligence powered mobile intervention focuses on reversing and controlling diabetes through integrated care.

COLLABORATION PARTNERSHIP

#insurance

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 12,2017

CEO of Fit4D (now named Cecelia Health), David Weingard, Announced as Finalist for the Lyfebulb-Novo Nordisk Innovation Summit and Award

The Summit and Award spotlights outstanding Patient Entrepreneurs’ innovative efforts and ideas to better manage diabetes via consumer products, medical devices, or healthcare information technology. Due to his growing impact as a patient-innovator in the diabetes space, this is the second time in a row that David has been selected for the honor.

View Analyst & Ambassador Comments
Go to original news
Oct 13,2017

Tandem Diabetes Care Announces Pricing of $16.2 Million Underwritten Public Offering of Common Stock and Warrants

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the pricing of an underwritten public offering of (i) 4,630,000 shares of its common stock, (ii) Series A warrants to purchase 4,630,000 shares of its common stock and (iii) Series B warrants to purchase 4,630,000 shares of its common stock, for gross proceeds of approximately $16.2 million, at a public offering price of $3.50 per share and accompanying warrants.

View Analyst & Ambassador Comments
Go to original news
Oct 13,2017

Changing Health reshapes Newcastle diabetes education in new NHS partnership

Changing Health, the service transforming digital education and support for people with Type 2 diabetes, is now available for thousands more people in Newcastle to rapidly improve their health outcomes. A new agreement between Changing Health and Newcastle Hospitals NHS Foundation Trust, which delivers healthcare services from six major sites across the city, means the entire Type 2 diabetes population covered by the Trust can now access the service. Around 25,000 people in Newcastle and Gateshead have Type 2 diabetes.

COLLABORATION PARTNERSHIP

#product & service

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 16,2017

Senseonics Holdings, Inc. Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE-MKT:SENS) today announced that it plans to release its third quarter 2017 financial results after market close on Tuesday, October 31, 2017. Management will hold a conference call to review the company's third quarter 2017 performance starting at 4:30 p.m. (Eastern Time) on the same day.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES